Overview

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with oral N-acetylcysteine (NAC) will improve behavior problems often associated with autism spectrum disorders.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborator:
National Alliance for Autism Research
Treatments:
Acetylcysteine
N-monoacetylcystine